SCLX
$8.15
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescript...
Recent News
Trending tickers: Datavault, Novo Nordisk, FedEx, SBI and NatWest
The latest investor updates on stocks that are trending on Monday
Scilex Holding Company's (NASDAQ:SCLX) top owners are retail investors with 57% stake, while 24% is held by private companies
Key Insights Scilex Holding's significant retail investors ownership suggests that the key decisions are influenced by...
Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
Datavault AI's multi-million-dollar geothermal deal and guidance upgrade signal that its strategic pivot to AI data monetization is gaining traction.
Datavault AI Aims For $200 Million In 2026
Bigger deals and global expansion give management fresh confidence
Datavault AI's 314% Upside: Huge Potential or Wall Street Mirage?
Datavault AI's analyst price target suggests monumental upside potential driven by major new licensing agreements and a proactive management team.